AB Science
Manufacturing · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3 Avenue George V, Paris, Ile-de-France,...Phone Number
+33 147200014Website
www.ab-science.comRevenue
<$5 MillionStock Symbol
ABIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About AB Science
AB Science, founded in 2001 and headquartered in Paris, France, is a pharmaceutical company focused on the research, development and commercialization of protein kinase inhibitors. These compounds target diseases with high unmet medical needs, including oncology, neurological diseases, inflammatory diseases, and viral diseases. AB Science has developed a proprietary portfolio of molecules, with its lead compound masitinib approved for veterinary medicine and in development for human medical applications. The company is publicly traded on Euronext Paris and maintains operations across Europe and North America.Explore more
AB Science Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AB Science your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on AB Science recently announced quarterly report
Click to see if AB Science had a recent Job posting/layoffs
Check if AB Science has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at AB Science
Funding: Get notified immidiatlly once AB Science has new funding data
Product Launch: Get notified when AB Science launches new products
Check out if AB Science is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
AB Science, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
AB Science is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AB Science is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AB Science.
AB Science financials insights
Gather financial insights about AB Science, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Share Placement
$18.3M
2021
Debt
$7.2M
2022
Debt
$8.5M
2025
Stock/Share Issuance
$2M
Stock/Share Issuance
$3.2M
2026
Stock/Share Issuance
$3.7M
Private Equity
$3M
AB Science Tech Stack
A closer look at the technologies used by AB Science
Most Recent Scoops
Funding
Funding
Earnings
Earnings, Finance
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Funding
Funding
AB Science News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AB Science
Sign Up For FreeTo access detailed company insights
AB Science, founded in 2001 and headquartered in Paris, France, is a pharmaceutical company focused on the research, development and commercialization of protein kinase inhibitors. These compounds target diseases with high unmet medical needs, including oncology, neurological diseases, inflammatory diseases, and viral diseases. AB Science has devel... Read More
